Summit Therapeutics Inc (SMMT)
4.42
+0.03
(+0.68%)
USD |
NASDAQ |
May 06, 15:38
Summit Therapeutics Price: 4.42 for May 6, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 4.08 | 4.50 | 4.06 | 4.39 | 1.861M |
| May 02, 2024 | 4.68 | 4.68 | 3.95 | 4.06 | 3.014M |
| May 01, 2024 | 3.92 | 4.99 | 3.90 | 4.70 | 5.653M |
| Apr 30, 2024 | 3.88 | 4.06 | 3.845 | 3.93 | 1.738M |
| Apr 29, 2024 | 3.88 | 4.06 | 3.855 | 3.88 | 1.458M |
| Apr 26, 2024 | 3.63 | 3.90 | 3.52 | 3.86 | 1.389M |
| Apr 25, 2024 | 3.52 | 3.62 | 3.44 | 3.55 | 1.407M |
| Apr 24, 2024 | 3.74 | 3.80 | 3.56 | 3.59 | 1.283M |
| Apr 23, 2024 | 3.48 | 3.925 | 3.48 | 3.73 | 1.755M |
| Apr 22, 2024 | 3.495 | 3.56 | 3.40 | 3.49 | 1.238M |
| Apr 19, 2024 | 3.50 | 3.55 | 3.34 | 3.50 | 1.728M |
| Apr 18, 2024 | 3.61 | 3.665 | 3.50 | 3.51 | 1.254M |
| Apr 17, 2024 | 3.57 | 3.63 | 3.47 | 3.57 | 1.373M |
| Apr 16, 2024 | 3.61 | 3.61 | 3.49 | 3.54 | 1.252M |
| Apr 15, 2024 | 3.69 | 3.80 | 3.615 | 3.655 | 887744.0 |
| Apr 12, 2024 | 4.01 | 4.065 | 3.625 | 3.665 | 1.362M |
| Apr 11, 2024 | 4.04 | 4.18 | 3.940 | 4.03 | 1.333M |
| Apr 10, 2024 | 3.922 | 4.12 | 3.90 | 4.00 | 3.193M |
| Apr 09, 2024 | 3.94 | 4.18 | 3.93 | 4.08 | 1.696M |
| Apr 08, 2024 | 3.90 | 4.06 | 3.80 | 3.95 | 1.590M |
| Apr 05, 2024 | 3.51 | 3.88 | 3.45 | 3.88 | 2.436M |
| Apr 04, 2024 | 3.82 | 3.961 | 3.48 | 3.54 | 2.337M |
| Apr 03, 2024 | 3.81 | 4.00 | 3.81 | 3.95 | 1.715M |
| Apr 02, 2024 | 3.94 | 4.07 | 3.83 | 3.85 | 1.574M |
| Apr 01, 2024 | 4.21 | 4.24 | 3.88 | 3.98 | 1.826M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6801
Minimum
Dec 01 2022
11.19
Maximum
Feb 08 2021
3.131
Average
2.395
Median
Price Benchmarks
| Retractable Technologies Inc | 1.09 |
| BioCardia Inc | 0.3938 |
| Alpine Immune Sciences Inc | 64.60 |
| Axsome Therapeutics Inc | 75.49 |
| Krystal Biotech Inc | 155.11 |
Price Related Metrics
| PS Ratio | 3234.89 |
| Price to Book Value | 70.18 |
| Earnings Yield | -2.71% |
| Market Cap | 3.103B |